Wealth Managers Favor Quality Bonds and Stocks in 2024
Explore why UBS and RBC Wealth Management are urging caution in equities and advocating for a focus on higher-quality segments in 2024.
As we approach 2024, wealth managers are showing a reluctance to take on significant risks, instead favoring quality bonds and stocks. UBS Global Wealth Management reported on Friday that the equity markets have had a shaky start in early 2024.
"At the close of US equity trading on Thursday, 10-year US Treasury yields had increased by 20 basis points since December, reaching 4 per cent, while the S&P 500 had declined by 2 per cent over the same period," UBS stated in a note. Investors have also reduced the likelihood of an early rate cut by the Federal Reserve to a market-implied probability of 66 per cent that the Fed will ease policy at its March policy meeting, down from 86 per cent at the end of last week. This has contributed to a third consecutive daily decline in the S&P 500, marking the first time since 2015 that the index has started the year with consecutive falls. This is part of a broader risk-off movement. High yield credit spreads have also widened, typically a sign of increasing risk aversion, according to UBS.
However, UBS believes that the recent movements are largely a reflection of the extent to which markets rallied in the final two months of 2023. The latest Fed minutes, while indicating some caution over the pace of cuts, continued to support the view that easing is on the way this year. The overall tone of the minutes released on Wednesday was less dovish than Fed Chair Jerome Powell's remarks at the press conference following the December meeting, during which he noted that policymakers had begun discussing lowering rates.
Among the more hawkish elements in the minutes, it was revealed that many policymakers felt that the rapid decline in government bond yields, leading to an easing of financial conditions, could make it more difficult for the Federal Open Market Committee to achieve its inflation goal. However, such comments were balanced by the observation by a number of participants that "downside risks to the economy" would arise if rates were kept restrictive for too long, UBS said. The prospect for rate cuts should also support stocks, albeit against a backdrop of more moderate growth. UBS continues to favor quality stocks – those issued by companies with strong balance sheets, high returns on invested capital, and a track record of delivering earnings.
As indicated last November, UBS expects Fed easing to support quality bonds and equities alike in 2024. RBC Wealth Management also echoed UBS' views on Friday, cautioning on equities in 2024. RBC WM maintains market weight positioning in equities overall, which aims to balance the risks of a US recession against the possibility that one may again be averted. The firm recommends tilting portfolios towards higher-quality segments of the equity market, including those companies with resilient balance sheets, sustainable dividends, and reliable cash flow generation.
As we enter 2024, wealth managers are displaying a preference for quality bonds and stocks, while exercising caution in the face of a shaky start in the equity markets. The prospect of rate cuts is expected to support stocks, albeit against a backdrop of more moderate growth. Both UBS Global Wealth Management and RBC Wealth Management are advocating for a cautious approach to equities in 2024, recommending a focus on higher-quality segments of the equity market.
Wealth Managers Favor Quality Bonds and Stocks in 2024
Foreign Investors Increase Purchases of Japanese Bonds Amid Speculation of Interest Rate Hike
Foreign investors have acquired a massive 1.15 trillion yen of Japanese bonds, signaling anticipation of Japan ending its negative interest rate policy.
Foreign investors have acquired a massive 1.15 trillion yen of Japanese bonds, signaling anticipation of Japan ending its negative interest rate policy.
Read moreU.S. Investors Flock to Money Market Funds, Largest Weekly Purchase Since Jan. 3
U.S. investors show strong interest in money market funds, purchasing $42.54 billion in the week leading up to Feb. 28 amidst uncertainties on interest rates and inflation.
U.S. investors show strong interest in money market funds, purchasing $42.54 billion in the week leading up to Feb. 28 amidst uncertainties on interest rates and inflation.
Read moreCash vs Stocks: Where Investors are Putting Their Money?
As stocks reach all-time highs, investors are turning to cash. Learn why this shift is happening and how it could impact your investment strategy.
As stocks reach all-time highs, investors are turning to cash. Learn why this shift is happening and how it could impact your investment strategy.
Read moreCanadian Green Bond Issuance Set to Rebound in 2024 After Sharp Decline
After a significant drop in 2023, Canadian green bond offerings are expected to surge in 2024, with companies raising $5.7 billion.
After a significant drop in 2023, Canadian green bond offerings are expected to surge in 2024, with companies raising $5.7 billion.
Read moreU.S. Regional Bank Stocks See Slight Recovery After NYCB Earnings Concerns
KBW Regional Banking Index gains 0.2% as NYCB shares rise 5% following two-day decline and Fitch downgrade. Get the latest updates on U.S. regional bank stocks.
KBW Regional Banking Index gains 0.2% as NYCB shares rise 5% following two-day decline and Fitch downgrade. Get the latest updates on U.S. regional bank stocks.
Read moreU.S. Equity Funds See Surge in Investor Interest Amid Positive Economic Indicators
U.S. equity funds experienced a $1.83 billion surge in investor interest, driven by strong economic growth and decreased inflation, marking the end of a four-week selling period.
U.S. equity funds experienced a $1.83 billion surge in investor interest, driven by strong economic growth and decreased inflation, marking the end of a four-week selling period.
Read moreCancer Drug Developer CG Oncology Surges 52.6% in Recent IPO
CG Oncology's recent IPO has made a significant impact, achieving a valuation of $1.75 billion and signaling a strong start for new listings in the market amidst increasing confidence in the U.S. economy.
CG Oncology\'s recent IPO has made a significant impact, achieving a valuation of $1.75 billion and signaling a strong start for new listings in the market amidst increasing confidence in the U.S. economy.
Read moreU.S. Equity Funds See Significant Outflows Amid Economic and Earnings Concerns
U.S. equity funds experienced major outflows as retail sales and Fed resistance dampened rate cut expectations, with investors selling a net total of $9.23 billion worth of funds.
U.S. equity funds experienced major outflows as retail sales and Fed resistance dampened rate cut expectations, with investors selling a net total of $9.23 billion worth of funds.
Read moreFrance Hires Banks to Sell New Green Bond Maturing in 2049
France has taken a significant step towards promoting environmentally-friendly initiatives by hiring banks to sell a new green bond that matures in 2049. This move reflects the country's commitment to green finance and sustainability.
France has taken a significant step towards promoting environmentally-friendly initiatives by hiring banks to sell a new green bond that matures in 2049. This move reflects the country\'s commitment to green finance and sustainability.
Read more